WOCKHARDT LIMITED (WOCKPHARMA) financials

WOCKHARDT LIMITED (WOCKPHARMA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).[1]

Market Cap: ₹32,273Cr.
Current Price: ₹1,986
Stock P/E: 97.5
ROE: 9.99%
ROCE: 9.74%
Book Value: ₹190
Dividend Yield: 0.00%
52W High / Low: ₹2,422/1,087

In Jun 2026, WOCKHARDT LIMITED (WOCKPHARMA) reported sales ₹561 Cr and net profit ₹107 Cr.

Annual TTM: sales ₹1,887 Cr, net profit ₹356 Cr.

Shareholding: Promoters 49.09% (Jun 2026), FIIs 7.23% (Jun 2026), DIIs 9.24% (Jun 2026), Government 0.02% (Jun 2026), Public 34.44% (Jun 2026).

WOCKPHARMA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	370	325	355	413	380	430	516	561
Expenses	321	263	249	282	267	317	355	403
Operating Profit	49	62	106	131	113	113	161	158
OPM %	13%	19%	30%	32%	30%	26%	31%	28%
Other Income	11	6	14	25	30	17	90	33
Interest	53	48	40	41	44	50	41	43
Depreciation	43	42	40	46	45	52	43	41
Profit before tax	-36	-22	40	69	54	28	167	107
Tax %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%
Net Profit	-36	-22	40	69	54	28	167	107
EPS in Rs	-2.35	-1.35	2.46	4.25	3.32	1.72	10.28	6.58
Raw PDF	—	—	—	—	—	—	—	—

WOCKPHARMA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	890	987	1,372	1,072	1,154	1,402	1,739	1,887
Expenses	1,023	1,125	1,150	1,002	1,190	1,102	1,222	1,342
Operating Profit	-133	-138	222	70	-36	300	517	545
OPM %	-15%	-14%	16%	7%	-3.1%	21%	30%	29%
Other Income	138	884	38	-168	27	55	162	170
Interest	220	200	273	229	237	199	176	178
Depreciation	173	184	171	186	176	168	186	181
Profit before tax	-389	362	-184	-513	-422	-12	317	356
Tax %	-41%	-64%	-24%	-9%	-0%	-0%	-0%	—
Net Profit	-231	593	-140	-466	-422	-12	317	356
EPS in Rs	-16.05	41.18	-9.72	-32.34	-27.51	-0.74	19.51	21.90
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	—

WOCKPHARMA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	55	55	55	72	72	77	81	81
Reserves	1,171	939	1,551	2,140	1,681	1,719	2,682	3,003
Borrowings	1,885	2,370	2,078	2,024	2,013	2,136	1,796	1,964
Other Liabilities	1,426	1,395	1,211	1,562	966	936	849	887
Total Liabilities	4,538	4,760	4,895	5,798	4,732	4,868	5,408	5,935
Fixed Assets	1,614	2,044	1,684	1,828	1,625	1,449	1,276	1,352
CWIP	381	305	716	825	823	833	1,260	1,397
Investments	297	297	297	297	297	297	719	709
Other Assets	2,245	2,113	2,198	2,848	1,987	2,289	2,153	2,477
Total Assets	4,538	4,760	4,895	5,798	4,732	4,868	5,408	5,935

WOCKPHARMA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	58	222	-563	-93	71	188	-14	241
Cash from Investing Activity	120	-16	1,014	-244	-3	-75	-900	-193
Cash from Financing Activity	-69	-274	-480	430	-236	346	486	-7
Net Cash Flow	109	-69	-29	93	-168	459	-428	41
Free Cash Flow	34	199	-1,088	-346	63	100	-508	-26
CFO/OP	-134%	-167%	328%	-6%	109%	-522%	-14%	47%

WOCKPHARMA shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	51.99%	49.09%	49.09%	49.09%	49.09%	49.09%	49.09%	49.09%
FIIs	6.70%	6.54%	6.82%	7.29%	7.10%	7.00%	7.09%	7.23%
DIIs	5.08%	9.82%	10.58%	11.00%	11.00%	10.55%	10.96%	9.24%
Government	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.04%	0.02%
Public	36.21%	34.54%	33.50%	32.60%	32.79%	33.36%	32.84%	34.44%
No. of Shareholders	1,38,142	1,42,710	1,41,799	1,46,918	1,37,946	1,42,274	1,39,016	1,66,518

WOCKPHARMA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	236	385	353	344	188	179	159	178
Inventory Days	195	367	305	297	330	254	357	469
Days Payable	325	611	355	446	507	459	398	442
Cash Conversion Cycle	105	141	303	194	11	-26	117	204
Working Capital Days	-52	-351	-334	-231	-404	-223	-7	72
ROCE %	-2%	-8%	-8%	2%	-1%	-4%	4%	10%

WOCKPHARMAUpdated 15 Oct 2026, 6:18

Wockhardt Limited

WOCKPHARMAUpdated 15 Oct 2026, 6:18

Market Cap

₹32,273Cr.

Current Price

₹1,986

High / Low

₹2,422/1,087

Stock P/E

97.5

ROE9.99%

ROCE9.74%

Book Value₹190

Face Value₹5.00

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Net Profit	EPS (₹)
Jun 2023	251	58	256	-8	44	-115	-115	-7.98
Sep 2023	260	59	270	6	44	-107	-107	-7.43
Dec 2023	288	61	263	5	43	-74	-74	-5.14
Mar 2024	355	59	401	24	45	-126	-126	-8.21
Jun 2024	352	58	272	27	43	6	6	0.39
Sep 2024	370	53	321	11	43	-36	-36	-2.35
Dec 2024	325	48	263	6	42	-22	-22	-1.35
Mar 2025	355	40	249	14	40	40	40	2.46
Jun 2025	413	41	282	25	46	69	69	4.25
Sep 2025	380	44	267	30	45	54	54	3.32
Dec 2025	430	50	317	17	52	28	28	1.72
Mar 2026	516	41	355	90	43	167	167	10.28
Jun 2026	561	43	403	33	41	107	107	6.58

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	1887	19	1879	465	103	350	5	332	23.19
Mar 2016	2217	108	2091	62	99	-20	-143	8	0.58
Mar 2017	2298	169	2153	248	106	119	-15	137	9.54
Mar 2018	2477	170	2154	57	106	104	34	69	4.77
Mar 2019	1557	171	1619	126	120	-227	-64	-82	-5.69
Mar 2020	890	220	1023	138	173	-389	-41	-231	-16.05
Mar 2021	987	200	1125	884	184	362	-64	593	41.18
Mar 2022	1372	273	1150	38	171	-184	-24	-140	-9.72
Mar 2023	1072	229	1002	-168	186	-513	-9	-466	-32.34
Mar 2024	1154	237	1190	27	176	-422	0	-422	-27.51
Mar 2025	1402	199	1102	55	168	-12	0	-12	-0.74
Mar 2026	1739	176	1222	162	186	317	0	317	19.51
TTM	1887	178	1342	170	181	356	—	356	21.9

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	49.09%
FIIs	7.23%
DIIs	9.24%
Government	0.02%
Public	34.44%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Sep 2023	55.14%	3.03%	0.21%	0%	41.62%
Dec 2023	54.93%	4.18%	0.3%	0%	40.59%
Mar 2024	51.6%	5.49%	4.82%	0.01%	38.06%
Jun 2024	51.99%	5.94%	4.45%	0.01%	37.62%
Sep 2024	51.99%	6.7%	5.08%	0.02%	36.21%
Dec 2024	49.09%	6.54%	9.82%	0.02%	34.54%
Mar 2025	49.09%	6.82%	10.58%	0.02%	33.5%
Jun 2025	49.09%	7.29%	11%	0.02%	32.6%
Sep 2025	49.09%	7.1%	11%	0.02%	32.79%
Dec 2025	49.09%	7%	10.55%	0.02%	33.36%
Mar 2026	49.09%	7.09%	10.96%	0.04%	32.84%
Jun 2026	49.09%	7.23%	9.24%	0.02%	34.44%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	55	1016	1138	1939	4149	1005	792	297	2054	4149
Mar 2016	55	1113	1984	1431	4584	1402	664	297	2221	4584
Mar 2017	55	1164	2120	1230	4569	1465	665	297	2142	4569
Mar 2018	55	1239	1773	1318	4386	1423	653	297	2013	4386
Mar 2019	55	1171	1885	1426	4538	1614	381	297	2245	4538
Mar 2020	55	939	2370	1395	4760	2044	305	297	2113	4760
Mar 2021	55	1551	2078	1211	4895	1684	716	297	2198	4895
Mar 2022	72	2140	2024	1562	5798	1828	825	297	2848	5798
Mar 2023	72	1681	2013	966	4732	1625	823	297	1987	4732
Mar 2024	77	1719	2136	936	4868	1449	833	297	2289	4868
Mar 2025	81	2682	1796	849	5408	1276	1260	719	2153	5408
Mar 2026	81	3003	1964	887	5935	1352	1397	709	2477	5935

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-53	203	425	575
Mar 2016	-363	-1015	764	-614
Mar 2017	-235	369	-133	1
Mar 2018	119	451	-524	46
Mar 2019	58	120	-69	109
Mar 2020	222	-16	-274	-69
Mar 2021	-563	1014	-480	-29
Mar 2022	-93	-244	430	93
Mar 2023	71	-3	-236	-168
Mar 2024	188	-75	346	459
Mar 2025	-14	-900	486	-428
Mar 2026	241	-193	-7	41

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	41	45	54	118	236	385	353	344	188	179	159	178
Inventory Days	240	216	206	141	195	367	305	297	330	254	357	469
Days Payable	158	134	133	167	325	611	355	446	507	459	398	442
Cash Conversion Cycle	123	126	127	92	105	141	303	194	11	-26	117	204
Working Capital Days	-223	-18	-73	-55	-52	-351	-334	-231	-404	-223	-7	72
ROCE %	20%	3%	9%	9%	-2%	-8%	-8%	2%	-1%	-4%	4%	10%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of WOCKHARDT LIMITED (WOCKPHARMA)?

The reported market capitalisation for WOCKHARDT LIMITED (WOCKPHARMA) is ₹32,273Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of WOCKPHARMA?

The current price shown for WOCKHARDT LIMITED (WOCKPHARMA) on Fincrux is ₹1,986 with a 52-week high/low of ₹2,422/1,087.

What is the P/E ratio of WOCKHARDT LIMITED (WOCKPHARMA)?

The stock P/E for WOCKHARDT LIMITED (WOCKPHARMA) is 97.5 on Fincrux, with ROE at 9.99% and ROCE at 9.74%.

What were WOCKPHARMA latest quarterly results?

For Jun 2026, WOCKHARDT LIMITED (WOCKPHARMA) reported sales ₹561 Cr and net profit ₹107 Cr (figures in ₹ crore unless noted).

What are WOCKPHARMA annual sales and net profit?

For TTM, WOCKHARDT LIMITED (WOCKPHARMA) shows sales of ₹1,887 Cr and net profit of ₹356 Cr on the Fincrux profit & loss statement.

Who owns WOCKHARDT LIMITED (WOCKPHARMA)?

Latest shareholding for WOCKHARDT LIMITED (WOCKPHARMA) on Fincrux: Promoters 49.09% (Jun 2026), FIIs 7.23% (Jun 2026), DIIs 9.24% (Jun 2026), Government 0.02% (Jun 2026), Public 34.44% (Jun 2026).

Where can I find WOCKHARDT LIMITED (WOCKPHARMA) financials?

WOCKHARDT LIMITED (WOCKPHARMA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show WOCKPHARMA balance sheet and cash flow?

Yes. The WOCKHARDT LIMITED (WOCKPHARMA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 15 October 2026 at 6:18